Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study

BACKGROUND: Etravirine (ETR) was approved for patients with virological failure and antiretroviral resistance mutations. It has also shown antiviral efficacy in antiretroviral-naïve patients. However, data on the switching from protease inhibitors (PI) to ETR are lacking. METHODS: HIV-1-infected pat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Echeverría, Patricia, Bonjoch, Anna, Puig, Jordi, Moltó, José, Paredes, Roger, Sirera, Guillem, Ornelas, Arelly, Pérez-Álvarez, Nuria, Clotet, Bonaventura, Negredo, Eugènia
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2014
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913576/
https://ncbi.nlm.nih.gov/pubmed/24503952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0084676
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki